NCCN Endorses Full COVID-19 Vaccination for Cancer Patients
Full COVID-19 vaccination, including third doses and/or boosters, is recommended for all patients with cancer, with a strong preference for mRNA vaccines.
Cancer
Risk for Infective Endocarditis In Patients With Staphylococcus aureus Bloodstream Infections, Cancer
Investigators conducted a study to assess the incidence and risk factors associated with infective endocarditis in patients with and without active cancer.
Efficacy of Short-Course Antibiotics for Bloodstream Infections in Patients With Acute Myeloid Leukemia, Febrile Neutropenia
Researchers conducted a study to compare the effects of short- vs long-course antibiotics for the treatment of bloodstream infections in patients with acute myeloid leukemia and chemotherapy-induced febrile neutropenia.
Cervical Cancer Deaths Down Following HPV Vaccine Introduction
Reductions in cervical cancer incidence, mortality in the U.S. greater for those aged 15 to 24 years than those aged 25 to 29, 30 to 39 years.
Effects of Mass vs Layered Closure on Incisional Surgical Site Infection Risk
Researchers conducted a study to compare the effects of mass vs layered closure on the risk for incisional surgical site infections among patients undergoing laparotomy via upper abdominal transverse incisions.
Cervical Cancer, CIN3 in Young Women Plummeted After HPV Vaccination
Fewer than expected cervical cancers, CIN3 cases seen among vaccinated cohorts after introduction of HPV immunization program in England.
Preferred Sedation Levels for Agitated Delirium in Terminal Patients Vary Between Nurses and Caregivers
A secondary analysis of data sought to determine the level of sedation for agitated delirium in patients with cancer at the end of life preferred by nurses and caregivers.
Increased Uptake of HPV Vaccine Projected to Reduce Oropharyngeal Cancer Incidence Over 25 Years
A new study projects that increasing HPV vaccination rates will trend toward reduced incidence of oropharyngeal cancer among younger adults until 2045.
Effect of a National Human Papillomavirus Immunization Program on Cervical Cancer Incidence
Researchers conducted a study to determine the effect of a national human papillomavirus (HPV) immunization program on the incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia among young women in England.
FMT: Can It Improve Immunotherapy Outcomes?
Further research is warranted to understand the potential ways fecal microbiota transplantations may improve patients’ responses to immunotherapy.
- Loading...
Loading...
Next post in General Infectious Disease
Loading... 
Loading...